Khatib, Alfi and Bakhtiar, M. Taher (2016) Comprehensive evaluation of anti-diabetic activity of momordica charantia fruits on streptozocin induced diabetic rats using NMR metabolomics approach. Research Report. UNSPECIFIED. (Unpublished)
PDF
- Submitted Version
Restricted to Repository staff only Download (624kB) | Request a copy |
Abstract
Momordica charantia is an excellent source of vitamins and minerals that made it extensively nutritious. Moreover, the seed, fruit and leave of the plant contain bioactive compounds with wide range of biological activities that have been used in traditional medicines in the treatment of several diseases, including inflammation, infections, obesity and diabetes. The aim of this study was to evaluate changes in urinary metabolites profile of the normal, streptozotocin-induced type 1 diabetic and M. charantia treated diabetic rats using proton nuclear magnetic resonance (1H-NMR) -based metabolomics profiling. Study had been carried out by inducing diabetes in the rats through injection of streptozotocin, which exhibited type 1 diabetes. M. charantia extract (100 and 200 mg/kg body weight) was administrated to the streptozotocin-induced diabetic rats for one week. Blood glucose level after administration was measured to examine hypoglycemic effect of the extract. The 1H-NMR-based metabolomics analysis of urine samples from the normal, diabetic control and diabetic treated rats were carried out to evaluate the discrimination between the treatments. The results obtained indicated that M. charantia was effective in lowering blood glucose level of the diabetic rats. The loading plot of Partial Least Square (PLS) component 1 showed that diabetic rats had increased levels of lactate and glucose in urine whereas normal and the extract treated diabetic rats had higher levels of succinate, creatine, creatinine, urea and phenylacetylglycine in urine. While the loading plot of PLS component 2 showed a higher levels of succinate, citrate, creatine, creatinine, sugars, and hippurate in urine of normal rat compared to the extract treated diabetic rat. Administration of M. charantia extract was found to be able to regulate the altered metabolic processes. Thus, it could be potentially used to treat the diabetic patients.
Item Type: | Monograph (Research Report) |
---|---|
Additional Information: | 6915/53432 |
Uncontrolled Keywords: | Momordica charantia, streptozotocin, type 1 diabetes, metaboloMomordica charantia, streptozotocin, type 1 diabetes, metabolomics, proton nuclear magnetic resonancemics, proton nuclear magnetic resonance |
Subjects: | Q Science > Q Science (General) |
Kulliyyahs/Centres/Divisions/Institutes (Can select more than one option. Press CONTROL button): | Kulliyyah of Pharmacy Kulliyyah of Pharmacy > Department of Pharmaceutical Chemistry |
Depositing User: | Dr. Alfi Khatib |
Date Deposited: | 28 Dec 2016 19:57 |
Last Modified: | 12 Dec 2018 15:44 |
URI: | http://irep.iium.edu.my/id/eprint/53432 |
Actions (login required)
View Item |